Transcription factors in the pathogenesis of diabetic nephropathy (Q37461601)

20 August 2017

1 reference

title

Transcription factors in the pathogenesis of diabetic nephropathy (English)

1 reference

20 August 2017

0 references

Amber Paratore Sanchez

series ordinal

1

1 reference

PubMed ID

19397838

20 August 2017

Kumar Sharma

series ordinal

2

1 reference

20 August 2017

28 April 2009

1 reference

Expert Reviews in Molecular Medicine

20 August 2017

1 reference

20 August 2017

11

1 reference

20 August 2017

e13

1 reference

Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells

20 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

The role of osteopontin in the development of albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Identification of a renal-specific oxido-reductase in newborn diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Up-regulation of human myo-inositol oxygenase by hyperosmotic stress in renal proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Decorin deficiency enhances progressive nephropathy in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice11See Editorial by Kasinath, p. 1918

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

The transcriptional regulatory code of eukaryotic cells--insights from genome-wide analysis of chromatin organization and transcription factor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

AP-1 complexes mediate oxidized LDL-induced overproduction of TGF-beta(1) in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Upstream stimulating factors: highly versatile stress-responsive transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

High glucose levels upregulate upstream stimulatory factor 2 gene transcription in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Aldose reductase regulates TGF-beta1-induced production of fibronectin and type IV collagen in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcription factors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Antiproliferative properties of the USF family of helix-loop-helix transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Mouse USF1 gene cloning: comparative organization within the c-myc gene family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

A natural classification of the basic helix-loop-helix class of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcription factors: structural families and principles of DNA recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Signal Transduction and the Control of Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Phosphorylation of cAMP responsive element binding protein after treatment of mesangial cells with high glucose plus TGF beta or PMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Histone deacetylase inhibitors: a novel class of therapeutic agents in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Introduction to NF-kappaB: players, pathways, perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcription factor-kappa B (NF-kappa B) and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcriptional regulation via the NF-kappaB signaling module.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Partners in transcription: NFAT and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

A code for transcription initiation in mammalian genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Transcription regulation and animal diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Gene expression and identification of gene therapy targets in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Genetic determinants of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Modulation of transcription factors by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Gene and protein markers of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Glucose-dependent liver gene expression in upstream stimulatory factor 2 -/- mice

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Transcription of the transforming growth factor-beta2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reductase in cultured human mesangial cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001057

7 January 2021

10.1017/S1462399409001057

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19397838